About deCODE Genetics
deCODE Genetics is a Healthcare company based in Reykjavik (Iceland) founded in 1996, and was acquired by Amgen in December 2012. Bioinformatics platform for genetic disease analysis is provided. deCODE Genetics has completed 1 acquisition, including UVS. Its website decode.com draws about 14 thousand monthly visits. deCODE Genetics offers products and services including Genome Analysis Platform and AI Splicing Prediction Tool. Its focus areas include Life Sciences, Genomics, Genomics Services and Bioinformatics.
Company details
Founded in 1996 in Reykjavik, Iceland, operations in the bioinformatics sector are conducted by deCODE Genetics. Genetic variations linked to diseases including cardiovascular, psychiatric, and cancer conditions are identified through a platform supported by extensive genotypic and medical data from 160,000 Icelandic volunteers. A genealogical database spanning nearly 1,000 years is maintained, facilitating large-scale disease studies with minimized bias and genotype imputation capabilities.
- Headquarters Reykjavik, Iceland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website decode.com
- Social LinkedIn X
- Acquired by Amgen (Dec 2012)
Products & Services of deCODE Genetics
deCODE Genetics offers a comprehensive portfolio of products and services, including Genome Analysis Platform and AI Splicing Prediction Tool.
Platform for identifying genetic variations linked to human diseases
Method to enhance accuracy of RNA splicing predictions in genetics
Funding Insights of deCODE Genetics
- Total Rounds 14
- Last Round Grant — $702,262
- First Round $6.24M
(May 2007)
- Investors Count 2
Latest 10 of 14 funding rounds of deCODE Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $702,262 | Grant | – | – | |
| Jan 2020 | $918,553 | Grant | – | – | |
| Jan 2019 | $6.24M | Grant | – | – | |
| Jan 2014 | Grant | – | – | ||
| Aug 2011 | $1.78M | Grant | – | – | |
| Feb 2011 | $550,325 | Grant | – | – | |
| Jan 2011 | $1.73M | Grant | – | – | |
| Sep 2010 | $1.57M | Grant | – | – | |
| Sep 2010 | $1.41M | Grant | – | – | |
| Sep 2007 | $550,325 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in deCODE Genetics
deCODE Genetics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Amgen, HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Developer of pharmaceutical products for treating multiple diseases | 1980 | amgen.com | Thousand Oaks, United States |
Investor details for deCODE Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of deCODE Genetics
19 people are tracked at deCODE Genetics (9 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Kári Stefánsson | CEO | Leadership |
Hreinn Stefánsson | Head of CNS | Leadership |
Gísli Másson | VP Informatics | Leadership |
Magnús Örn Úlfarsson | Head of Artificial Intelligence | Leadership |
Bjarni V. Halldórsson | Head of Sequence Analysis | Leadership |
Lára Ingólfsdóttir | CFO | Leadership |
Magnus Ulfarsson | Head Of Artificial Intelligence | Leadership |
Nanna Vidarsdottir | Director Of HR | Leadership |
Agnar Helgason | Head of Anthropology | Leadership |
Árni Sigurðsson | System Administrator | Team |
Johann Hjartarson | General Counsel, CCO & DPO | Team |
Anna Thora Petursdottir | Research Scientist | Team |
Einar Örn Bergsson | Software Developer | Team |
Gunnar Þór Sigurðsson | Data Administrator And Bioinformatics Specialist | Team |
Saedis Saevarsdottir | Researcher | Team |
Guillaume Holley | Research Scientist | Team |
Sindri Snær Sigurðarson | Research Associate | Team |
Aron Skaftason | Bioinformatics Developer | Team |
Kris Moore | Senior Research Associate | Team |
Complete people profiles for deCODE Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by deCODE Genetics
deCODE Genetics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include UVS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cancer research is conducted via population genomic studies. | uvs.is | Reykjavik, Iceland | 1999 | Jan 2006 | $5.5M |
Complete acquisition details for deCODE Genetics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of deCODE Genetics
6 dated milestones of deCODE Genetics across 25 years, from founding to its latest funding, stage changes and deals.
Web traffic of deCODE Genetics
The website of deCODE Genetics (decode.com) receives about 13.6K visits a month.
- Monthly visits13.6K
▼ 18.3% vs previous month
Websites whose visitors overlap most with deCODE Genetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| navigenics.com | 100% | View details | |||
| somalogic.com | 90% | 15.6K | #1,626,420 | View details | |
| illumina.com | 76% | 672.7K | #61,793 | View details | |
| celera.com | 74% | View details | |||
| hum-molgen.org | 74% | #11,260,715 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for deCODE Genetics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Decode Genetics
Complete news archive for deCODE Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about deCODE Genetics
deCODE Genetics was founded in 1996 and raised its 1st funding round 11 years after it was founded.
deCODE Genetics is headquartered in Reykjavik, Iceland.
Founded in 1996 in Reykjavik, Iceland, operations in the bioinformatics sector are conducted by deCODE Genetics. Genetic variations linked to diseases including cardiovascular, psychiatric, and cancer conditions are identified through a platform supported by extensive genotypic and medical data from 160,000 Icelandic volunteers. A genealogical database spanning nearly 1,000 years is maintained, facilitating large-scale disease studies with minimized bias and genotype imputation capabilities.
deCODE Genetics offers Genome Analysis Platform and AI Splicing Prediction Tool.
deCODE Genetics has made 1 acquisition, including UVS.
deCODE Genetics has 3 investors. Key investors include Amgen, HHS, and European Union.
Yes. deCODE Genetics was acquired by Amgen in December 2012.